Anti-HIV activity of betulinic acid analogue YKFJ312

Drug Discovery Today

Volumn 6, Issue 16, 2001, Pages 859-861

  Walker, Michael A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 87830; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BETULIC ACID; MEVINOLIN; NATURAL PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; YKFH 312;

ANTIVIRAL ACTIVITY; DRUG ACTIVITY; DRUG DEVELOPMENT; FIBROBLAST; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOPRENYLATION; NONHUMAN; SHORT SURVEY; VIRUS REPLICATION;

EID: 0035882243     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01911-0     Document Type: Short Survey

References (5)

1. Anti-human immunodeficiency virus activity of YK-FH312 (a betulininc acid derivative), a novel compound blocking viral maturation
2. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infection
3. Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores
4. Antiviral activity of lovastatin against respiratory synceytial virus in vivo and in vitro
5. Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration